News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Lichter Jay
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| Lichter Jay (10% Owner) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $13.22, valued at
$165.3k
|
|
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| Lichter Jay (10% Owner) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Converted 1,138,665 shares
@ $0
Converted 2,382,191 shares
@ $0
Converted 674,211 shares
@ $0
Converted 2,696,843 shares
@ $0
Converted 1,153,238 shares
@ $0
Bought 629,411 shares
@ $17, valued at
$10.7M
Converted 888,888 options to buy
@ $0
Converted 1,859,634 options to buy
@ $0
Converted 526,316 convertible preferred
@ $0
Converted 2,105,264 convertible preferred
@ $0
Converted 900,264 convertible preferred
@ $0 |
|
| 06/14/2021 |
4
| Lichter Jay (10% Owner) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $17, valued at
$510k
|
|
| 06/10/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2020 |
4
| Lichter Jay (Director) has filed a Form 4 on Synthorx, Inc.|
Txns:
| Unknown transaction of 150,000 shares
@ $68, valued at
$10.2M
Unknown transaction of 448,567 shares
@ $68, valued at
$30.5M
Unknown transaction of 1,682,086 shares
@ $68, valued at
$114.4M
Disposed/sold 30,000 options to buy
@ $11, valued at
$330k
Disposed/sold 15,335 options to buy
@ $12.4, valued at
$190.2k
|
|
| 01/16/2020 |
4
| Lichter Jay (Director) has filed a Form 4 on Synthorx, Inc.|
Txns:
| Disposed of 4,598,796 shares
@ $0
Acquired 448,567 shares
@ $0 |
|
| 06/13/2019 |
4
| Lichter Jay (Director) has filed a Form 4 on OTONOMY, INC.|
Txns:
| Granted 17,500 options to buy
@ $2.35, valued at
$41.1k
|
|
| 06/10/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2018 |
4
| Lichter Jay (10% Owner) has filed a Form 4 on Synthorx, Inc.|
Txns:
| Converted 1,281,664 shares
@ $0
Converted 762,617 shares
@ $0
Converted 2,517,278 shares
@ $0
Converted 1,136,631 shares
@ $0
Bought 545,455 shares
@ $11, valued at
$6M
Converted 2,053,534 preferred shares
@ $0
Converted 1,221,896 preferred shares
@ $0
Converted 4,033,283 preferred shares
@ $0
Converted 1,821,156 preferred shares
@ $0 |
|
| 12/07/2018 |
4
| Lichter Jay (10% Owner) has filed a Form 4 on Synthorx, Inc.|
Txns:
| Granted 30,000 options to buy
@ $11, valued at
$330k
|
|
| 12/06/2018 |
3
| Lichter Jay (10% Owner) has filed a Form 3 on Synthorx, Inc. |
| 06/20/2018 |
4
| Lichter Jay (Director) has filed a Form 4 on OTONOMY, INC.|
Txns:
| Granted 17,500 options to buy
@ $4.45, valued at
$77.9k
|
|
| 09/05/2017 |
4
| Lichter Jay (Director) has filed a Form 4 on OTONOMY, INC.|
Txns:
| Paid exercise price by delivering 108,851 shares
@ $18.37, valued at
$2M
Exercised 14,106 options to buy
@ $14.18, valued at
$200k
|
|
| 07/14/2017 |
4
| Lichter Jay (Director) has filed a Form 4 on OTONOMY, INC.|
Txns:
| Granted 15,000 options to buy
@ $16.05, valued at
$240.8k
|
|
| 06/21/2016 |
4
| Lichter Jay (Director) has filed a Form 4 on Otonomy, Inc. |
| 07/17/2015 |
4
| Lichter Jay (Director) has filed a Form 4 on ARATANA THERAPEUTICS, INC.|
Txns:
| Disposed of 1,000,000 shares
@ $0 |
|
| 06/22/2015 |
4
| Lichter Jay (Director) has filed a Form 4 on Otonomy, Inc.|
Txns:
| Granted 15,000 options to buy
@ $22.12, valued at
$331.8k
|
|
| 06/19/2015 |
4
| Lichter Jay (Director) has filed a Form 4 on ARATANA THERAPEUTICS, INC.|
Txns:
| Granted 10,000 options to buy
@ $14.27, valued at
$142.7k
|
|
| 08/19/2014 |
4
| Lichter Jay (10% Owner) has filed a Form 4 on Otonomy, Inc.|
Txns:
| Converted 740,057 shares
@ $0
Converted 660,580 shares
@ $0
Sold 50,001 shares
@ $16, valued at
$800k
Converted 705,598 shares
@ $0
Bought 109,375 shares
@ $16, valued at
$1.8M
Converted 337,432 preferred shares
@ $0
Converted 175,889 preferred shares
@ $0
Converted 484,691 preferred shares
@ $0
Converted 568,828 preferred shares
@ $0
Converted 136,770 preferred shares
@ $0
Converted 6,432 options to buy
@ $31.092, valued at
$200k
|
|
| 06/23/2014 |
4
| Lichter Jay (10% Owner) has filed a Form 4 on ARATANA THERAPEUTICS, INC.|
Txns:
| Granted 10,000 options to buy
@ $15.03, valued at
$150.3k
|
|
| 02/05/2014 |
4
| Lichter Jay (10% Owner) has filed a Form 4 on ARATANA THERAPEUTICS, INC.|
Txns:
| Sold 825,000 shares
@ $19, valued at
$15.7M
|
|
| 02/04/2014 |
4/A
| Lichter Jay (10% Owner) has filed a Form 4 on ARATANA THERAPEUTICS, INC.|
Txns:
| Bought 500,000 shares
@ $6, valued at
$3M
|
|
| 07/03/2013 |
4
| Lichter Jay (10% Owner) has filed a Form 4 on ARATANA THERAPEUTICS, INC.|
Txns:
| Converted 3,434,616 shares
@ $0
Converted 4,000,000 convertible preferred
@ $0
Converted 1,333,333 convertible preferred
@ $0
Converted 375,000 convertible preferred
@ $0 |
|
| 06/28/2013 |
4
| Lichter Jay (10% Owner) has filed a Form 4 on ARATANA THERAPEUTICS, INC.|
Txns:
| Granted 21,058 options to buy
@ $6, valued at
$126.3k
|
|
| 06/26/2013 |
3
| Lichter Jay (10% Owner) has filed a Form 3 on ARATANA THERAPEUTICS, INC. |
| 06/20/2008 |
4
| Lichter Jay (President and CEO) has filed a Form 4 on AKESIS PHARMACEUTICALS, INC.|
Txns:
| Granted 500,000 options to buy
@ $0.51, valued at
$255k
Granted 500,000 options to buy
@ $0.66, valued at
$330k
|
|
| 11/14/2006 |
4
| Lichter Jay (President and CEO) has filed a Form 4 on AKESIS PHARMACEUTICALS, INC.|
Txns:
| Granted 500,000 options to buy
@ $0.94, valued at
$470k
|
|
|
|